These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28625003)

  • 1. When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development.
    Oraiopoulos N; Dunlop WCN
    Adv Ther; 2017 Jul; 34(7):1572-1583. PubMed ID: 28625003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving models of collaborative drug discovery: managing intellectual capital assets.
    Allarakhia M
    Expert Opin Drug Discov; 2018 Jun; 13(6):473-476. PubMed ID: 29569503
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crowdsourcing in pharma: a strategic framework.
    Bentzien J; Bharadwaj R; Thompson DC
    Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.
    Wilson R; Godfrey CM; Sears K; Medves J; Ross-White A; Lambert N
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):146-55. PubMed ID: 26571290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are academic drug discovery efforts receiving more recognition with declining industry efficiency?
    Bryans JS; Kettleborough CA; Solari R
    Expert Opin Drug Discov; 2019 Jul; 14(7):605-607. PubMed ID: 30907161
    [No Abstract]   [Full Text] [Related]  

  • 9. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ReRouting biomedical innovation: observations from a mapping of the alternative research and development (R&D) landscape.
    Greenberg A; Kiddell-Monroe R
    Global Health; 2016 Sep; 12(1):54. PubMed ID: 27627882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Market failure in the pharmaceutical industry and how it can be overcome: the CureShare mechanism.
    Levy M; Rizansky A
    Eur J Health Econ; 2014 Mar; 15(2):143-56. PubMed ID: 23417217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmaceuticalisation of society? A framework for analysis.
    Williams SJ; Martin P; Gabe J
    Sociol Health Illn; 2011 Jul; 33(5):710-25. PubMed ID: 21371048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Customer relationship management in the contract pharmaceutical industry: an exploratory study for measuring success.
    Kros JF; Nadler S; Molis J
    Int J Electron Healthc; 2007; 3(3):353-66. PubMed ID: 18048307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessing external innovation in drug discovery and development.
    Tufféry P
    Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizational effectiveness: a key to R&D productivity.
    Tollman P; Panier V; Dosik D; Biondi P; Cuss F
    Nat Rev Drug Discov; 2016 Jul; 15(7):441-2. PubMed ID: 27312725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Academic drug discovery: current status and prospects.
    Everett JR
    Expert Opin Drug Discov; 2015; 10(9):937-44. PubMed ID: 26088126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
    Litten RZ; Ryan M; Falk D; Fertig J
    Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.